Login / Signup

Ablation for Benign Liver Tumors: Current Concepts and Limitations.

Hitoshi MaruyamaMaki TobariHiroaki NagamatsuTadashi YamaguchiShuichiro Shiina
Published in: Journal of clinical and translational hepatology (2022)
Percutaneous ablation under imaging guidance is a curative treatment that can induce complete tumor necrosis with advantages of minimal invasiveness and a low risk of complications. Thermal ablation, which includes radiofrequency ablation and microwave ablation, is a representative technique that has sufficient antitumor effects in cases of hepatocellular carcinoma with ≤3 lesions measuring ≤3 cm and preserved liver function. The short- and long-term outcomes of patients are comparable with those achieved with surgical resection. Despite their nonmalignant nature, some benign liver tumors require treatment for symptoms caused by the presence of the tumor and/or continuous enlargement. Ablation may be the treatment of choice because it has lower burden on patients than surgical treatment. This review describes the recent concepts, progress, and limitations of ablation-based treatment for benign liver tumors.
Keyphrases
  • radiofrequency ablation
  • ejection fraction
  • prognostic factors
  • newly diagnosed
  • minimally invasive
  • risk factors
  • mass spectrometry
  • fluorescence imaging